Optimizing platelet transfusion thresholds based on TEG maximum clot strength (MA value) to reduce platelet usage and improve patient outcomes in liver transplantation: a cohort study.

Front Med (Lausanne) · 2026 · PMC13050902 · PMID 41948583

Europe PMC DOI

hedged sentences

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

approached significanceP = 0.051so close (0.05 < p ≤ 0.1)

While the difference in red blood cell (RBC) transfusion rates approached significance, with 68.8% of the CPCT group and 56.3% of the TEG group receiving RBC transfusions ( P = 0.051), it did not reach statistical significance.

also in 3,083 other papers

a trend toward significanceno p-value reported

AST levels showed a trend toward significance with 83.6 ± 28.7 IU/ml in the CPCT group compared to 76.5 ± 25.8 IU/ml in the TEG group, though not reaching statistical significance ( P = 0.055).

also in 1,881 other papers

did not reach statistical significanceno p-value reported

While the difference in red blood cell (RBC) transfusion rates approached significance, with 68.8% of the CPCT group and 56.3% of the TEG group receiving RBC transfusions ( P = 0.051), it did not reach statistical significance.

also in 57,577 other papers

showed a trendno p-value reported

AST levels showed a trend toward significance with 83.6 ± 28.7 IU/ml in the CPCT group compared to 76.5 ± 25.8 IU/ml in the TEG group, though not reaching statistical significance ( P = 0.055).

also in 24,669 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.